natgillin/translations-raw huggingface dataset:
Replacing saturated fats with unsaturated fats in the diet has been shown to lower/reduce blood cholesterol.
Nadomestitev nasičenih maščob z nenasičenimi maščobami v prehrani dokazano znižuje/zmanjšuje raven holesterola v krvi.
High cholesterol is a risk factor in the development of coronary heart disease
Povišan holesterol je dejavnik tveganja za razvoj koronarne srčne bolezni.
The claim may be used only for food which is high in unsaturated fatty acids, as referred to in the claim HIGH UNSATURATED FAT as listed in the Annex to Regulation (EC) No 1924/2006
Trditev se lahko navede le na živilu, ki je bogato z nenasičenimi maščobnimi kislinami, kakor je opredeljeno s trditvijo VISOKA VSEBNOST NENASIČENIH MAŠČOB iz Priloge k Uredbi (ES) št. 1924/2006.
The claim proposed by the applicant was worded as follows: ‘Replacing a fat rich in saturated/trans fatty acids by a fat rich in unsaturated fatty acids helps to reduce LDL cholesterol.
EFSA-Q-2009-00458) [2].
LDL cholesterol is a cardiovascular risk factor’.
Vložnik je predlagal naslednjo trditev: „Nadomestitev maščob, bogatih z nasičenimi ali transmaščobnimi kislinami, z maščobami, bogatimi z nenasičenimi maščobnimi kislinami, pomaga zniževati LDL-holesterol.
EFSA Journal 2011; 9(5):2168.
UL L 404, 30.12.2006, str. 9.
Commission Implementing Regulation (EU) No 1227/2014
Izvedbena uredba Komisije (EU) št. 1227/2014
fixing an adjustment rate for direct payments provided for in Council Regulation (EC) No 73/2009 in respect of calendar year 2014 and repealing Commission Implementing Regulation (EU) No 879/2014
o določitvi prilagoditvene stopnje za neposredna plačila, določene v Uredbi Sveta (ES) št. 73/2009, za koledarsko leto 2014 in razveljavitvi Izvedbene uredbe Komisije (EU) št. 879/2014
Having regard to Regulation (EU) No 1306/2013 of the European Parliament and of the Council of 17 December 2013 on the financing, management and monitoring of the common agricultural policy and repealing Council Regulations (EEC) No 352/78, (EC) No 165/94, (EC) No 2799/98, (EC) No 814/2000, (EC) No 1290/2005 and (EC) No 485/2008 [1], and in particular Article 26(4) thereof,
ob upoštevanju Uredbe (EU) št. 1306/2013 Evropskega parlamenta in Sveta z dne 17. decembra 2013 o financiranju, upravljanju in spremljanju skupne kmetijske politike in razveljavitvi uredb Sveta (EGS) št. 352/78, (ES) št. 165/94, (ES) št. 2799/98, (ES) št. 814/2000, (ES) št. 1290/2005 in (ES) št. 485/2008 [1], ter zlasti člena 26(4) Uredbe,
On 21 March 2014 the Commission adopted a proposal for a Regulation of the European Parliament and of the Council on fixing an adjustment rate for direct payments provided for in Council Regulation (EC) No 73/2009 in respect of calendar year 2014 [2].
Komisija je 21. marca 2014 sprejela predlog Uredbe Evropskega parlamenta in Sveta o določitvi prilagoditvene stopnje za neposredna plačila, določene v Uredbi Sveta (ES) št. 73/2009, za koledarsko leto 2014 [2].
The European Parliament and the Council had not set that adjustment rate by 30 June 2014.
Evropski parlament in Svet do 30. junija 2014 nista določila navedene prilagoditvene stopnje.
Therefore, in accordance with Article 26(3) of Regulation (EU) No 1306/2013, the Commission has set the adjustment rate in Commission Implementing Regulation (EU) No 879/2014 [3].
Zato je v skladu s členom 26(3) Uredbe (EU) št. 1306/2013 Komisija prilagoditveno stopnjo določila v Izvedbeni uredbi Komisije (EU) št. 879/2014 [3].
The forecasts for the direct payments and market related expenditure included in Commission Amending Letter No 1 to the 2015 Draft Budget show the need to adapt the rate of financial discipline which was taken into account in the Draft Budget 2015.
Napovedi za neposredna plačila in odhodke, povezane s trgom, iz dopolnilnega pisma Komisije št. 1 k predlogu proračuna za leto 2015 kažejo, da je treba prilagoditi stopnjo v okviru finančne discipline, ki je bila upoštevana v predlogu proračuna za leto 2015.
That Amending Letter has been established taking into account an amount of financial discipline of EUR 433 million for the reserve for crises in the agricultural sector referred to in Article 25 of Regulation (EU) No 1306/2013.
Navedeno dopolnilno pismo je bilo pripravljeno ob upoštevanju zneska v okviru finančne discipline v višini 433 milijonov EUR za rezervo za krizne razmere v kmetijskem sektorju iz člena 25 Uredbe (EU) št. 1306/2013.
In order to take account of this new information, the Commission should adapt the adjustment rate set in Implementing Regulation (EU) No 879/2014.
Zaradi upoštevanja teh novih informacij bi Komisija morala prilagoditi prilagoditveno stopnjo, določeno v Izvedbeni Uredbi (EU) št. 879/2014.
As a general rule, farmers submitting an aid application for direct payments for one calendar year (N) are paid within a fixed payment period falling under the financial year (N+1).
Praviloma kmetje, ki vložijo vlogo za pomoč za neposredna plačila za eno koledarsko leto (N), plačilo prejmejo v predpisanem plačilnem obdobju, ki spada pod proračunsko leto (N + 1).
When financial discipline is applied for a given calendar year, the adjustment rate should not be applied to payments for which aid applications have been submitted in the calendar years other than that for which the financial discipline applies.
Pri uporabi finančne discipline za dano koledarsko leto se prilagoditvena stopnja ne bi smela uporabljati pri plačilih, za katera so bile vloge za pomoč vložene v koledarskih letih, za katera se finančna disciplina ne uporablja.
Therefore, in order to ensure equal treatment of farmers, it is appropriate to provide that the adjustment rate is only applied to payments for which aid applications have been submitted in the calendar year for which the financial discipline is applied, irrespectively of when the payment to farmers is made.
Zato je za zagotovitev enakega obravnavanja kmetov primerno določiti, da se prilagoditvena stopnja uporablja samo za plačila, za katera so bile vloge za pomoč vložene v koledarskem letu, za katero se finančna disciplina uporablja, ne glede na to, kdaj se plačilo kmetom izvede.
Article 8(1) of Regulation (EU) No 1307/2013 of the European Parliament and of the Council [4] lays down that the adjustment rate applied to direct payments determined in accordance with Article 26 of Regulation (EU) No 1306/2013 applies only to direct payments in excess of EUR 2000 to be granted to farmers in the corresponding calendar year.
V členu 8(1) Uredbe (EU) št. 1307/2013 Evropskega parlamenta in Sveta [4] je določeno, da se prilagoditvena stopnja za neposredna plačila, določena v skladu s členom 26 Uredbe (EU) št. 1306/2013, uporablja samo za neposredna plačila, višja od 2000 EUR, ki se odobrijo kmetom v ustreznem koledarskem letu.
Furthermore Article 8(2) of Regulation (EU) No 1307/2013 provides that as a result of the gradual introduction of direct payments, the adjustment rate applies only to Bulgaria and Romania from 1 January 2016 and to Croatia from 1 January 2022.
Poleg tega je v členu 8(2) Uredbe (EU) št. 1307/2013 določeno tudi, da se zaradi postopnega uvajanja neposrednih plačil prilagoditvena stopnja za Bolgarijo in Romunijo uporablja šele od 1. januarja 2016, za Hrvaško pa od 1. januarja 2022.
The adjustment rate to be determined by the present Regulation should therefore not apply to payments to farmers in those Member States.
Prilagoditvena stopnja, ki se določi v tej uredbi, se ne bi smela uporabljati za plačila kmetom v navedenih državah članicah.
In order to ensure that the adapted adjustment rate is applicable as from the date on which the payments to farmers are to start in accordance with Regulation (EU) No 1306/2013, this Regulation should apply from 1 December 2014.
Za zagotovitev, da se prilagojena stopnja uporablja od datuma, ko bi bilo treba začeti z izplačili kmetom v skladu z Uredbo (EU) št. 1306/2013, bi bilo treba to uredbo uporabljati od 1. decembra 2014.
The adapted adjustment rate should be taken into account for the calculation of all payments to be granted to a farmer for an aid application submitted in respect of calendar year 2014.
Prilagojeno prilagoditveno stopnjo bi bilo treba upoštevati za izračun vseh plačil, ki se dodelijo kmetu na podlagi vloge za pomoč, vložene za koledarsko leto 2014.
For the sake of clarity, Implementing Regulation (EU) No 879/2014 should therefore be repealed,
Zaradi jasnosti bi zato bilo treba Izvedbeno uredbo (EU) št. 879/2014 razveljaviti –
For the purpose of applying the adjustment provided for in Articles 25 and 26 of Regulation (EU) No 1306/2013 and in accordance with Article 8(1) of Regulation (EU) No 1307/2013, the amounts of the payments within the meaning of Article 2(d) of Council Regulation (EC) No 73/2009 [5] to be granted to a farmer in excess of EUR 2000 for an aid application submitted in respect of calendar year 2014 shall be reduced by 1,302214 %.
Za uporabo prilagoditve iz členov 25 in 26 Uredbe (EU) št. 1306/2013 ter v skladu s členom 8(1) Uredbe (EU) št. 1307/2013 se zneski plačil v smislu člena 2(d) Uredbe Sveta (ES) št. 73/2009 [5], ki presegajo 2000 EUR in se dodelijo kmetu na podlagi vloge za pomoč, vložene za koledarsko leto 2014, znižajo za 1,302214 %.
The reduction provided for in paragraph 1 shall not apply in Bulgaria, Croatia and Romania.
Znižanje iz odstavka 1 se ne uporablja v Bolgariji, Romuniji in na Hrvaškem.
Implementing Regulation (EU) No 879/2014 is repealed.
Izvedbena uredba (EU) št. 879/2014 se razveljavi.
Commission Implementing Regulation (EU) No 879/2014 of 12 August 2014 fixing an adjustment rate for direct payments provided for in Council Regulation (EC) No 73/2009 in respect of calendar year 2014 (OJ L 240, 13.8.2014, p. 20).
Izvedbena uredba Komisije (EU) št. 879/2014 z dne 12. avgusta 2014 o določitvi prilagoditvene stopnje za neposredna plačila, določene v Uredbi Sveta (ES) št. 73/2009, za koledarsko leto 2014 (UL L 240, 13.8.2014, str. 20).
Regulation (EU) No 1307/2013 of the European Parliament and of the Council of 17 December 2013 establishing rules for direct payments to farmers under support schemes within the framework of the common agricultural policy and repealing Council Regulation (EC) No 637/2008 and Council Regulation (EC) No 73/2009 (OJ L 347, 20.12.2013, p. 608).
Uredba (EU) št. 1307/2013 Evropskega parlamenta in Sveta z dne 17. decembra 2013 o pravilih za neposredna plačila kmetom na podlagi shem podpore v okviru skupne kmetijske politike ter razveljavitvi Uredbe Sveta (ES) št. 637/2008 in Uredbe Sveta (ES) št. 73/2009 (UL L 347, 20.12.2013, str. 608).
Furthermore Article 8(2) of Regulation (EU) No 1307/2013 provides that as a result of the gradual introduction of direct payments, the adjustment rate applies only to Bulgaria and Romania from 1 January 2016 and to Croatia from 1 January 2022.
ob upoštevanju Uredbe (ES) št. 1924/2006 Evropskega parlamenta in Sveta z dne 20. decembra 2006 o prehranskih in zdravstvenih trditvah na živilih [1] in zlasti člena 17(3) Uredbe,
The adjustment rate to be determined by the present Regulation should therefore not apply to payments to farmers in those Member States.
V skladu z Uredbo (ES) št. 1924/2006 so zdravstvene trditve na živilih prepovedane, razen če jih Komisija v skladu z navedeno uredbo odobri in uvrsti na seznam dovoljenih trditev.
Commission Regulation (EU) No 1228/2014
Uredba (ES) št. 1924/2006 določa tudi, da nosilci živilske dejavnosti lahko vloge za odobritev zdravstvenih trditev predložijo pristojnemu nacionalnemu organu države članice.
authorising and refusing to authorise certain health claims made on foods and referring to the reduction of disease risk
Pristojni nacionalni organ veljavne vloge pošlje Evropski agenciji za varnost hrane (v nadaljnjem besedilu: Agencija).
(Text with EEA relevance)
Agencija po prejemu vloge takoj obvesti druge države članice in Komisijo ter pripravi mnenje o zadevni zdravstveni trditvi.
Having regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods [1], and in particular Article 17(3) thereof,
Komisija ob upoštevanju mnenja Agencije odloči o odobritvi zdravstvenih trditev.
Pursuant to Regulation (EC) No 1924/2006 health claims made on foods are prohibited unless they are authorised by the Commission in accordance with that Regulation and included in a list of permitted claims.
Družba Abtei Pharma Vertriebs GmbH je v skladu s členom 14(1)(a) Uredbe (ES) št. 1924/2006 vložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki kalcija in vitamina D3 v žvečilnih tabletah na preprečevanje izgube kostne mase (vprašanje št.
Regulation (EC) No 1924/2006 also provides that applications for authorisations of health claims may be submitted by food business operators to the national competent authority of a Member State.
EFSA-Q-2008-721) [2].
The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as ‘the Authority’.
Vložnik je predlagal naslednjo trditev:
Following receipt of an application the Authority is to inform without delay the other Member States and the Commission thereof, and to deliver an opinion on the health claim concerned.
„Žvečilne tablete s kalcijem in vitaminom D izboljšajo kostno gostoto pri ženskah po 50. letu starosti.
The Commission is to decide on the authorisation of health claims taking into account the opinion delivered by the Authority.
Tako lahko žvečilne tablete zmanjšajo tveganje za zlome zaradi osteoporoze.“
Following an application from Abtei Pharma Vertriebs GmbH, submitted pursuant to Article 14(1)(a) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to Calcium and vitamin D3 chewing tablets and bone loss (Question No EFSA-Q-2008-721) [2].
Agencija je na podlagi predloženih podatkov v mnenju, ki so ga Komisija in države članice prejele 7. avgusta 2009, ugotovila, da je vzročno-posledična povezava med uživanjem kalcija, bodisi samostojno ali v kombinaciji z vitaminom D, in zmanjšanjem izgube mineralne kostne gostote (MKG) pri ženskah po menopavzi utemeljena.
The claim proposed by the applicant was worded as follows:
Zmanjšanje izgube MKG lahko prispeva k zmanjšanju tveganja za zlome kosti.
‘Chewing tablets with calcium and vitamin D improve bone density in women 50 years and older.
Zdravstveni trditvi, ki odražata to ugotovitev, bi zato bilo treba šteti za skladni z zahtevami iz Uredbe (ES) št. 1924/2006 in ju uvrstiti na seznam dovoljenih trditev Unije.
Thus chewing tablets may reduce the risk of osteoporotic fractures’.
Vendar je Agencija ugotovila, da predložene informacije niso bile zadostne za določitev pogojev uporabe trditev.
On the basis of the data presented, the Authority concluded in its opinion received by the Commission and the Member States on 7 August 2009 that a cause and effect relationship had been established between the intake of calcium, either alone or in combination with vitamin D, and reducing the loss of bone mineral density (BMD) in postmenopausal women.
Zato se je Komisija ponovno obrnila na Agencijo za dodatni nasvet, ki bi odgovornim za obvladovanje tveganja omogočil, da določijo ustrezne pogoje uporabe zadevnih zdravstvenih trditev.
Reducing the loss of BMD may contribute to a reduction in the risk of bone fractures.
Agencija je v mnenju, ki so ga Komisija in države članice prejele 17. maja 2010 (vprašanje št.
Accordingly, two health claims reflecting this conclusion should be considered as complying with the requirements of Regulation (EC) No 1924/2006, and should be included in the Union list of permitted claims.
EFSA-Q-2009-00940) [3], ugotovila, da je za doseganje navedenega učinka potrebno zaužiti vsaj 1200 mg kalcija iz vseh virov ali vsaj 1200 mg kalcija in 800 i.e.
However, the Authority concluded that the information provided was insufficient to establish conditions of use for the claims.
(20 μg) vitamina D iz vseh virov.
Subsequently, the Commission went back to the Authority to seek further advice to enable the risk managers to set appropriate conditions of use for the relevant health claims.
Kadar se zdravstvena trditev uporablja le za kalcij, je za zagotovitev, da živilo vsebuje zadostno količino kalcija, primerno določiti pogoje uporabe, ki določajo uporabo trditve le na živilih, ki zagotavljajo vsaj 400 mg kalcija v količinsko določenem obroku.
The Authority concluded in its opinion received by the Commission and the Member States on 17 May 2010 (Question No EFSA-Q-2009-00940) [3] that at least 1200 mg of calcium from all sources or at least 1200 mg of calcium and 800 I.U.
Kadar se zdravstvena trditev uporablja za kombinacijo kalcija in vitamina D, je treba za doseganje navedenega učinka zaužiti precejšnjo količino vitamina D (20 μg), zato je primerno uporabo trditve omejiti na prehranska dopolnila.
(20 μg) of vitamin D from all sources should be consumed daily in order to obtain the claimed effect.
Za zagotovitev, da prehransko dopolnilo, na katerem se uporablja navedena trditev, zagotavlja znatno količino kalcija in vitamina D, je primerno določiti pogoje uporabe, ki določajo uporabo trditve le na prehranskih dopolnilih, ki zagotavljajo vsaj 400 mg kalcija in 15 μg vitamina D v dnevnem obroku.
When the health claim is made only on calcium, in order to ensure that a food provides a significant quantity of calcium, it is appropriate to set conditions of use which allow the claim to be made only on foods which provide at least 400 mg of calcium per quantified portion.
Družba DSM Nutritional Products Europe AG je v skladu s členom 14(1)(a) Uredbe (ES) št. 1924/2006 vložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki vitamina D na tveganje za padce pri moških in ženskah po 60. letu starosti (vprašanje št.
Taking into account the high level of vitamin D intake required to achieve the claimed effect (20 μg), when the health claim is made on the combination of calcium and vitamin D, it is appropriate to limit the use of the claim to food supplements.
EFSA-Q-2010-01233) [4].
In order to ensure that a food supplement would provide a significant quantity of calcium and vitamin D in the context of this claim, it is appropriate to set conditions of use which allow the claim to be made only on food supplements which provide at least 400 mg of calcium and 15 μg of vitamin D per daily portion.
„Vitamin D zmanjša tveganje za padce.
Following an application from DSM Nutritional Products Europe AG, submitted pursuant to Article 14(1)(a) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of vitamin D and risk of falling for men and women 60 years of age and older (Question No EFSA-Q-2010-01233) [4].
Padci so dejavnik tveganja za zlome.“
‘Vitamin D reduces the risk of falling.
Agencija je na podlagi predloženih podatkov v mnenju, ki so ga Komisija in države članice prejele 30. septembra 2011, ugotovila, da je vzročno-posledična povezava med uživanjem vitamina D in zmanjšanjem tveganja za padce, ki so posledica posturalne nestabilnosti in mišične oslabelosti, utemeljena.
Falling is a risk factor for fractures’.
Zmanjšanje tveganja za padce pri moških in ženskah po 60. letu starosti je koristno za zdravje ljudi, saj se zmanjša tveganje za kostne zlome.
On the basis of the data presented, the Authority concluded in its opinion received by the Commission and the Member States on 30 September 2011 that a cause and effect relationship had been established between the intake of vitamin D and a reduction in the risk of falling, which is positively associated with postural instability and muscle weakness.
Zdravstveno trditev, ki odraža to ugotovitev, bi zato bilo treba šteti za skladno z zahtevami iz Uredbe (ES) št. 1924/2006 in jo uvrstiti na seznam dovoljenih trditev Unije.
A reduction in the risk of falling among men and women 60 years of age and older is beneficial to human health by reducing the risk of bone fractures.
Agencija je v mnenju tudi ugotovila, da je treba za doseganje navedenega učinka dnevno zaužiti 800 i.e.
Accordingly, a health claim reflecting this conclusion should be considered as complying with the requirements of Regulation (EC) No 1924/2006, and should be included in the Union list of permitted claims.
(20 μg) vitamina D iz vseh virov.
In its opinion, the Authority also concluded that 800 I.U.
Ker je treba za doseganje navedenega učinka zaužiti precejšnjo količino vitamina D (20 μg), je primerno uporabo trditve omejiti na prehranska dopolnila.
(20 μg) of vitamin D, from all sources, should be consumed daily in order to obtain the claimed effect.
Za zagotovitev, da prehransko dopolnilo, na katerem se uporablja navedena trditev, zagotavlja znatno količino vitamina D, je primerno določiti pogoje uporabe, ki določajo uporabo trditve le na prehranskih dopolnilih, ki zagotavljajo vsaj 15 μg vitamina D v dnevnem obroku.
Taking into account the high level of vitamin D intake required to achieve the claimed effect (20 μg), it is appropriate to limit the use of the claim to food supplements.
Člen 16(4) Uredbe (ES) št. 1924/2006 določa, da bi moralo mnenje, ki podpira odobritev zdravstvene trditve, vključevati nekatere podatke.
In order to ensure that a food supplement would provide a significant quantity of vitamin D in the context of this claim, it is appropriate to set conditions of use which allow the claim to be made only on food supplements which provide at least 15 μg of vitamin D per daily portion.
Navedene podatke v zvezi z odobrenimi trditvami bi zato bilo treba določiti v Prilogi I k tej uredbi ter vanje vključiti, odvisno od primera, spremenjeno besedilo trditve, posebne pogoje uporabe trditve in, kadar je to ustrezno, pogoje ali omejitve uporabe živila in/ali dodatno pojasnilo ali opozorilo v skladu s pravili iz Uredbe (ES) št. 1924/2006 in mnenji Agencije.
Article 16(4) of Regulation (EC) No 1924/2006 provides that an opinion in favour of authorising a health claim should include certain particulars.
Eden od ciljev Uredbe (ES) št. 1924/2006 je zagotoviti, da so zdravstvene trditve resnične, jasne, zanesljive in uporabne za potrošnika ter da se pri tem upoštevata besedilo in predstavitev trditve.
Accordingly, those particulars should be set out in Annex I to this Regulation as regards the authorised claims and include, as the case may be, the revised wording of the claim, specific conditions of use of the claim, and, where applicable, conditions or restrictions of use of the food and/or an additional statement or warning, in accordance with the rules laid down in Regulation (EC) No 1924/2006 and in line with the opinions of the Authority.
Kadar ima besedilo trditev za potrošnike enak pomen kot odobrena zdravstvena trditev, ker je med njima ista povezava kot med kategorijo živila, živilom ali njegovo sestavino in zdravjem, bi bilo treba te trditve uporabljati pod istimi pogoji, kot so navedeni v Prilogi I k tej uredbi.
One of the objectives of Regulation (EC) No 1924/2006 is to ensure that health claims are truthful, clear and reliable and useful to the consumer, and that wording and presentation are taken into account in that respect.
Družba GP International Holding B.V. je v skladu s členom 14(1)(a) Uredbe (ES) št. 1924/2006 vložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki glukozamin hidroklorida na zmanjšanje hitrosti degeneracije hrustanca (vprašanje št.
Therefore where the wording of claims has the same meaning for consumers as that of an authorised health claim, because they demonstrate the same relationship that exists between a food category, a food or one of its constituents and health, they should be subject to the same conditions of use indicated in Annex I to this Regulation.
EFSA-Q-2009-00412) [5].
Following an application from GP International Holding B.V., submitted pursuant to Article 14(1)(a) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to glucosamine hydrochloride and reduced rate of cartilage degeneration (Question No EFSA-Q-2009-00412) [5].
„Upočasni/zmanjša postopek uničevanja hrustanca v mišično-skeletnem sistemu in posledično zmanjša tveganje za osteoartritis.“